Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-08-05

Clinical Trial Update: Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of food on eradication rates of Helicobacter pylori with triple therapy including esomeprazole has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: EMS | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: WITHDRAWN